ArticleAnnals of surgical oncology2019

Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.

Susie Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.